4//SEC Filing
GRAHAM RICHARD A 4
Accession 0001415889-23-009963
CIK 0001583107other
Filed
Jun 15, 8:00 PM ET
Accepted
Jun 16, 6:14 PM ET
Size
4.7 KB
Accession
0001415889-23-009963
Insider Transaction Report
Form 4
GRAHAM RICHARD A
SVP, Development
Transactions
- Sale
Ordinary Shares
2023-06-14$10.69/sh−2,322$24,822→ 354,390 total
Footnotes (1)
- [F1]This transaction was executed in accordance with the reporting person's 10b5-1 plan dated 11/23/22.
Documents
Issuer
Theravance Biopharma, Inc.
CIK 0001583107
Entity typeother
Related Parties
1- filerCIK 0001820036
Filing Metadata
- Form type
- 4
- Filed
- Jun 15, 8:00 PM ET
- Accepted
- Jun 16, 6:14 PM ET
- Size
- 4.7 KB